Furthermore, in the context of CNS cancers like glioblastoma, BATF2 expression has been shown to limit tumor growth primarily by altering the tumor microenvironment with minimal impact on the proliferation of glioma cells, as indicated by analysis of proliferating cell nuclear antigen, a common marker of DNA replication and proliferation (39). This evidence concerns the gene BATF2 and glioblastoma.